Patient characteristics (n=50)
| Age, years | 74±14 |
| Female gender, n (%) | 18 (36) |
| BMI (kg/m2) | 25±5 |
| Clinical features, n (%) | |
| Arterial hypertension | 33 (66) |
| Hyperlipidaemia | 20 (40) |
| Diabetes mellitus | 7 (14) |
| Coronary artery disease | 19 (38) |
| Previous MI | 14 (28) |
| Previous PCI | 12 (24) |
| Previous CABG | 7 (14) |
| Left ventricular ejection fraction (%) | 47±18 |
| Previous valve surgery | 4 (8) |
| Previous vascular/thoracic surgery | 2 (4) |
| Atrial fibrillation | 33 (66) |
| COPD | 7 (14) |
| Previous stroke | 4 (8) |
| Impaired renal function | 28 (56) |
| Cancer | 2 (4) |
| NYHA functional class, n (%) | |
| II | 7 (14) |
| III | 34 (68) |
| IV | 9 (18) |
| Surgical risk | |
| Logistic EuroSCORE, % | 26±14 |
| STS mortality score, % | 7±6 |
| STS mortality and morbidity score, % | 35±19 |
Data are given as mean±SD unless otherwise stated.
BMI, body mass index; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; EuroSCORE, European System for Cardiac Operative Risk Evaluation; MI, myocardial infarction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; STS, Society of Thoracic Surgeons.